# A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures

> **NCT00522041** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 248 (actual)

## Conditions studied

- Fissure in Ano
- Pain

## Interventions

- **DRUG:** Cellegesic
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00522041
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00522041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00522041, "A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00522041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
